Financials • Accident &Health Insurance
$113.65 ▲ +1.81
(+1.62%)
MKT CAP: $24.33B • VOL: 1.35M
52W L $80 52W H $121
PFG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $15.63B | $16.13B | $13.67B |
| YoY Revenue Growth % | -3.1% | +18.0% | — |
| Gross Profit | $6.88B | $7.10B | $6.01B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.48B | $1.89B | $790.7M |
| Operating Margin % | 9.5% | 11.7% | 5.8% |
| Net Income (GAAP) | $1.26B | $1.60B | $670.1M |
| EBITDA (Normalized) | $2.04B | $2.47B | $1.28B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.54B | $4.60B | $3.79B |
| Capital Expenditures (CapEx) | $703.1M | $725.7M | $615.0M |
| Free Cash Flow (FCF) | $3.83B | $3.88B | $3.18B |
| FCF Margin % | 24.5% | 24.0% | 23.3% |
| Return on Invested Capital (ROIC %) | 0.8% | 1.0% | 6.3% |
| Cash & Short-Term Equivalents | $4.43B | $4.21B | $1.80B |
| Total Debt (Short + Long Term) | $148.04B | $135.99B | $3.84B |
| Total Stockholders' Equity | $11.88B | $11.09B | $7.87B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR PFG.